India’s biotech industry a “sunrise sector”
27-Sep-2008 - Indian pharmaceutical companies are making their first forays in the biotechnology arena, helping the...
Phylogeny launches first in situ miRNA detection service
23-Sep-2008 - Phylogeny has launched the first microRNA (miRNA) in situ hybridisation detection service to help scientists...
ChanTest to increase range of ion channel services
23-Sep-2008 - Ion channel expert ChanTest is expanding its range of ion channel services and cell lines...
Joint API inspection service to cut costs
22-Sep-2008 - Germany-based Diapharm has launched a service allowing pharmaceutical manufacturers to perform joint third-party audits of...
Pharmaceutical Profiles the effects of diabetes drug
18-Sep-2008 - UK-based Pharmaceutical Profiles has used an imaging technique known as scintigraphy to quantify the...
High-potency unit opens at Phamatek
18-Sep-2008 - Pharmatek Laboratories has opened its highly-potent and cytotoxic facility located in San Diego, US, just...
Charles River expands Discovery Services
17-Sep-2008 - Charles River Laboratories has agreed to buy US-based drug discovery imaging expert Molecular Imaging...
Pharma outsourcing: people on the move
17-Sep-2008 - Outsourcing-Pharma.com presents its latest round-up of new appointments, employment moves and personnel news in the...
Assay Depot: ‘Ebay’ for drug discovery services debuts
16-Sep-2008 - Assay Depot, a new online marketplace which allows bench researchers around the world to...
Boom times continue for Indian CMOs
15-Sep-2008 - India’s contract manufacturing market is expected to rocket forward over the next couple of...
Patheon slashes losses in Q3
08-Sep-2008 - Canada’s Patheon put in another quarter of robust revenues growth in its third quarter,...
CSL snaps up Talecris for $3.1bn
14-Aug-2008 - Australia’s CSL Ltd has signed a $3.1bn agreement to acquire Talecris Biotherapeutics of the...
Research business lifts Charles River in 2Q
11-Aug-2008 - Charles River Laboratories saw its operating income advance 16 per cent to $77m in the...
Lilly sells R&D campus to Covance in pioneering deal
07-Aug-2008 - Eli Lilly took a giant leap down the outsourcing road yesterday with the sale...
Return to the black for PharmaNet
04-Aug-2008 - PharmaNet has reported a stellar set of second-quarter results, reversing its year-earlier loss with...
Medtox sees dip in clinical lab services, but profits rise
24-Jul-2008 - Laboratory services and diagnostics company Medtox Scientific has posted a healthy hike in operating profits...
Small molecules drive Lonza contract unit in 1H
24-Jul-2008 - Lonza of Switzerland is reaping the benefit of a shift away from bulk chemicals and...
Contract research news in brief
24-Jul-2008 - Outsourcing-Pharma.com rounds up recent developments among contract research organisations, including WuXi PharmaTech, AMRI, Physiomics, Biofocus...
Pharmaceutical outsourcing: people on the move
22-Jul-2008 - Outsourcing-Pharma.com presents its periodic round-up of personnel changes in the pharmaceutical outsourcing arena, with...
Weekly comment
Globalisation of advanced R&D services 'on the rise'
17-Jul-2008 - Pharmaceutical companies in the developed world have already shifted substantial manufacturing and clinical trial work...
Ranbaxy claims big pharma company behind falsification accusations
17-Jul-2008 - Ranbaxy has claimed that a pharmaceutical company is making a concerted effort to depress the...
INC trims down but says growth plans are on track
10-Jul-2008 - US contract research organisation (CRO) INC Research has cut some of its workforce at its...
Counterfeiting conference to hear of burden in developing world
26-Jun-2008 - Visiongain's third annual conference on Pharmaceutical Anti-counterfeiting Strategies kicks off next week, covering many aspects...
Patheon shifts HQ as reshaping continues
19-Jun-2008 - Patheon, fresh from announcing a new corporate brand and logo, has continued its makeover by...
Almac creates separate oncology division
19-Jun-2008 - Ireland's Almac Group has announced the creation of a new oncology division that will focus...
